CHICAGO / Feb 22, 2024 / Business Wire / Veradigm Inc. (NASDAQ: MDRX), a leading provider of healthcare data and technology solutions, announced today that it will be highlighting the new Veradigm Payer Insights solution at the ViVE 2024 conference in Los Angeles, CA, Feb 25-28. Veradigm will be exhibiting at booth #1461.
Gap closure is an important element in driving improved overall patient care and outcomes, but providers are not always aware of every gap that exists for their patients. If documentation of those gaps is not accessible at the point of care, during the provider’s usual workflow for the patient visit, there may be a reduction in potential positive impact on care.
As part of the Veradigm Network, Veradigm Payer Insights is a dynamic new solution which payers can use to deliver care gap alerts to their providers, within the patient’s electronic health record (EHR) system. Alerts contain relevant, patient-specific considerations for the provider to evaluate, respond and address with the patient.
"We are excited to be at ViVE 2024 sharing the power of Veradigm Payer Insights, another example of how the Veradigm Network is adding value for all healthcare stakeholders from payers to providers and beyond,” said Tom Langan, Veradigm President and Chief Commercial Officer. "Veradigm is leveraging its unique position at the nexus of payers, providers and life sciences to deliver transformational solutions that drive improved clinical and financial outcomes for all, and we are gratified to be able to share our perspective and hear directly from our customers and peers at the conference.”
About Veradigm®
Veradigm is a healthcare technology company that drives value through its unique combination of platforms, data, expertise, connectivity, and scale. The Veradigm Network features a dynamic community of solutions and partners providing advanced insights, technology, and data-driven solutions for the healthcare provider, payer, and biopharma markets. For more information about how Veradigm is fulfilling its mission of Transforming Health, Insightfully, visit www.veradigm.com, or find Veradigm on LinkedIn, Facebook, Twitter, and YouTube.
© 2024 Veradigm Inc. and/or its affiliates. All Rights Reserved.
| Last Trade: | US$9.75 |
| Daily Change: | 2.94 43.17 |
| Daily Volume: | 800 |
| Market Cap: | US$1.050B |
February 27, 2024 January 10, 2024 January 09, 2024 January 02, 2024 | |
Cue Biopharma is developing the first-ever class of therapeutics for the treatment of cancer that mimic the natural signals, or “Cues”, of the immune system. This novel class of injectable biologics selectively engages and modulates tumor-specific T cells directly within the patient’s body to transform...
CLICK TO LEARN MORE
Amneal Pharmaceuticals is a fully-integrated essential medicines company. We make healthy possible through the development, manufacturing, and distribution of generic and specialty pharmaceuticals. The Company has a diverse portfolio of over 250 products in its Generics segment and is expanding across...
CLICK TO LEARN MORE
